Atlanta Consulting Group Advisors »

Amneal Pharmaceuticals shares owned by Atlanta Consulting Group Advisors

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Atlanta Consulting Group Advisors from 13F filings

Historical chart of Atlanta Consulting Group Advisors investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Atlanta Consulting Group Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Atlanta Consulting Group Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $100k 10k 10.01
2025-06-30 $81k 10k 8.09
2024-12-31 $79k 10k 7.92
2024-09-30 $83k 10k 8.32
2024-06-30 $64k 10k 6.35
2024-03-31 $61k 10k 6.06

More positions owned by Atlanta Consulting Group Advisors

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alliance Resource Partners L Ut Ltd Part (ARLP)
Ishares Tr Core S&p Mcp Etf (IJH)
2023 Etf Series Trust Eagle Capital Se (EAGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
JPMorgan Chase & Co. (JPM)
Microsoft Corporation (MSFT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Ishares Core Msci Emkt (IEMG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Coca-Cola Company (KO)

View all positions for Atlanta Consulting Group Advisors

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Millennium Management
Nuveen
Acadian Asset Management
Morgan Stanley
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals